摘要
Pulmonary fibrosis(PF)is a chronic and progressively fatal disease,but clinically available therapeutic drugs are limited due to efficacy and side effects.The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II(AEC2),and activation of immune cells such as macrophages.The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts,endothelia cells and epithelia cells,and regulating macrophage polarization.Therefore,this study proposes an“ion therapy”approach based on the active ions of bioceramic materials,and investigates the therapeutic effect of bioactive ions derived from calcium silicate(CS)bioceramics on mouse models of pulmonary fibrosis.We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages.This result suggests potential clinical applications of ion therapy for lung fibrosis.
基金
This study was financially supported by the Ministry of Science and Technology of the People’s Republic of China(Grant Nos.2016YFC1100200 and 2016YFC1100204 and 2016YFC1100201)
the National Natural Science Foundation of China(Grant Nos.81730002,81670055,81670056,91442103,81500052,32000945 and 81570057)
National Science&Technology Major Project for Key New Drug Creation and Manufacturing Program(No:2018ZX09201002-006)
National Science Foundation of Shanghai(18ZR143400)
Shanghai Family Planning Commission Health Industry Clinical Research Project(Grant No.20184Y0084).
